Sandra Revill Tremulis: The Major Trial Testing Whether Lp(a) Lowering Saves Lives
Sandra Revill Tremulis, Marketing Consultant at Tremulis Stractical Marketing Consulting and Founder of the Lipoprotein(a) Foundation, shared a post on LinkedIn about a recent article by Leslie Cho et al, published in American Heart Journal:
“ Pelacarsen — the major trial testing whether Lp(a) lowering saves lives
Pelacarsen outcomes program — Lp(a)HORIZON trial design/rationale
Executive summary: Defines the pivotal outcomes framework for Lp(a): large, multinational, placebo-controlled phase 3 trial in established CVD with elevated Lp(a), testing whether targeted Lp(a) lowering reduces MACE. Value for clinicians/researchers: clarifies inclusion thresholds, endpoints, event-driven design, and the intended inferential strategy—useful when interpreting forthcoming results and planning complementary studies (imaging, biomarkers, implementation).
This is one of the most important trials in cardiovascular medicine today.”
Title: Design and Rationale of Lp(a)HORIZON Trial: Assessing the Effect of Lipoprotein(a) Lowering With Pelacarsen on Major Cardiovascular Events in Patients With CVD and Elevated Lp(a)
Authors: Leslie Cho , Stephen J Nicholls , Børge G Nordestgaard , Ulf Landmesser , Sotirios Tsimikas , Michael J Blaha , Eran Leitersdorf , A Michael Lincoff , Anastasia Lesogor , Brian Manning , Plamen Kozlovski , Hui Cao , Jing Wang , Steven E Nissen
Read the Full Article in American Heart Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?